ABSTRACT
INTRODUCTION
Uracil residues may be introduced into DNA as a result of incorporation of dUMP instead of dTMP (1-3) or deamination of cytosine residues in DNA (4). In both cases the incorrect base can be removed by the enzyme uracil-DNA glycosylase (reviewed in ref. 5 ) . This enzyme hydrolyses the bond between uracil and deoxyribose, thus releasing free uracil from DNA (5). The enzyme has been purified to homogeneity (6) or near homogeneity (7) from prokaryotic cells, and recently from human leukemia cells (8) . The significance of uracil-DNA glycosylase in vivo in E.coli was indicated by a five-fold increase in the spontaneous mutation rate and a fifteen-fold increase in G:C to A:T transitions in mutants (ung~) lacking this enzyme (9) . Similar mutants of animal cells are not available. In the present work we have partially purified and characterized a human uracil-DNA glycosylase with special regard to the enzyme's substrate requirements and the effect of uracil analogs.
MATERIALS AND METHODS
All non-radioactive nucleotides were purchased from PL Biochemicals. Nucleosides, bases and base analogs were from Sigma. Radioactively labeled nucleotides and nucleosides were obtained from the Radiochemical Centre, Amersham. DEAE-cellulose (DE-52) and phospho-cellulose ( P -l l ) were obtained from Whatman and hydroxyl apatite (Bio-Gel HT) from Bio-Rad. Sephadex G-100 was from Pharmacia. E.coli pol I and a fragment of E.coli pol I (Klenow fragment A) lacking 5'->3' exonuclease were purchased from Boehringer-Mannheim, and micrococcal nuclease and phospho-diesterase I I from bovine spleen from Worthington. Homogenous phospholipase C from B.cereus was a generous g i f t from Prof. C. L i t t l e of this i n s t i t u t e . Other chemicals and reagents were obtained as previously described ( 2 ) .
Preparation of cell extracts
HeLa S 3 cells were grown in suspension cultures as described previously (10) . Cells to be used for enzyme purification were harvested by c e n t r i f ugation (300 g x 10 min at 37°C) when they had reached a density of 3-4-x 10 cells/ml and then washed in ice-cold buffer A (10 mM Tris-HCl, pH 7.5, 3 mM MgCl-. 2 mM EGTA and 2 mM 2-mercaptoethanol) by resuspension and centrifugation (680 g x 5 min at 2°C). Cells collected in this way were stored at -70°C u n t i l they were used. A total of 1.2 x 10 cells were thawed in 170 ml of ice-cold buffer A supplemented with 1 mM phenylmethylsul fonyl fluoride and broken in a Dounce homogenizer ( t i g h t f i t t i n g pestle). Then 85 ml of buffer B (340 mM Tris-HCl, pH 8 . 1 , 3 mM MgCl 2 , 150 mM glucose, 2 mM EGTA and 0.15% (w/v) Triton X-100) were added and mixed with the cell lysate which was centrifuged (680 g x 5 min at 2°C). The nuclei (pellet) and crude cytosol (supernatant) were collected separately. The nuclear fraction was washed once in 50 ml of buffer C (which is a 2:1 mixture of buffers A and B) and the supernatant after centrifugation was combined with the crude cytosol. The combined supernatants (330 ml) were subjected to ultra-centrifugation (100 000 x g, 60 min, 2°C) in an SW 27 Beckman rotor. The pellet was discarded and the supernatant dialyzed twice against 20 vol of dialysis buffer (20 mM Tris-HCl, pH 7.5, 20% glycerol, 0.1% Triton X-100, 2 mM 2-mercaptoethanol and 1 mM phenylmethylsul fonyl fluoride (cytosol).
Preparation of uracil-DNA glycosylase All procedures were carried out at 4°C. Chromatography on DEAE-cellu-lose: two columns (3.5 cm x 20 cm) were equilibrated with the dialysis buffer described above and dialyzed cytosol applied to the column which was subsequently washed with one column volume of the same buffer. The adsorbed proteins were then eluted with a 900 ml linear gradient of KC1 (0-0.4 M) in dialysis buffer and fractions of 10 ml collected. Uracil-DNA glycosylase activity was tested in 2.5 pi aliquots and active fractions pooled. Chromatography on phosphocellulose: pooled fractions from the DEAE-cellulose column were applied to a phosphocellulose column (3 cm x 20 cm), equilibrated with 20 mM potassium phosphate, pH 7.5, 20% glycerol, 2 mM 2-mercaptoethanol, 0.1% Triton X-100 and 1 mM phenylmethylsulfonylfluoride. The column was washed with one column volume of the equilibration buffer and eluted with a 200 ml linear gradient of potassium phosphate pH 7.5 (0-0.3 M) with 20% glycerol, 2 mM 2-mercaptoethanol, 0.1% Triton X-100 and 1 mM PMSF. Fractions of 5 ml were collected and 2.5 pi aliquots tested for uracil-DNA glycosylase activity. Active fractions were pooled and concentrated by ultrafiltration (membrane PM 10, Amicon). Gel filtration on Sephadex G-100: A G-100 column (2.6 cm x 93 cm) was equilibrated with 10 mM Tris-HCl, pH 7.4, 10 mM NaCl and 1 mM EDTA (TEN) and the concentrated enzyme fraction from the phosphocellulose step applied to the column which was eluted at a rate of 0.27 ml/min. Fractions of 4 ml were collected and 3 pi aliquots assayed for uracil-DNA glycosylase activity. Active fractions were pooled. ]dUMP residues were located internally in DNA, since 97% of the radioactivity was degraded to 3'-dUMP and the rest to deoxyuridine.
As a control for the pur i t y of the commercially obtained enzymes, [ H]dTMP-labeled SV40 form I DNA (having no termini) was degraded similarly. After degradation, 2% of the radioactivity was found in the form of thymidine and the rest as dTMP. This shows that under our assay conditions, contaminating monoesterase a c t i v i t y represents a minor problem which can be corrected for by using circular DNA as control. A DNA substrate with [ H]dUMP at the 3'-OH end was prepared as described in Materials and Methods. About 96% of the incorporated [ H]dUMP was at the 3'-OH end as determined by the assay described above (Materials and Methods). 
Purification of uracil-DNA glycosylase
Uracil-DNA glycosylase was purified according to the procedure described in Materials and Methods (table 1). Using the subcellular fractionation procedures described, about 80% of the uracil-DNA glycosylase activity was found in cytosol and the rest in the nuclear fraction. This must not be taken to mean that the major part of uracil-DNA glycosylase is found in cytosol jjn vi_-vo, since redistribution may have taken place during cell fractionations.
Partially purified uracil-DNA glycosylase was unstable at 4°C, but in the presence of bovine serum albumin (0.5-1 mg/ml) and 50% glycerol, the enzyme activity was stable both during long term storage at -20°C and during 10-30 min incubations at 30 C. The final enzyme preparation contained no detectable DNA exonuclease activity since less than 0.03 pmole of acid-soluble radioactivity was released when 10 units of the enzyme were incubated with [ However, the preparation of uracil-DNA glycosylase appeared to contain a small amount of Mg -independent endonuclease. To detect contaminating endo-_2 nuclease activity, 10 units of enzyme were incubated for 60 min with 0.1 yg Only part of the material from the DEAE cellulose step (335 ml) was applied to the phosphocellulose column. (by vof.) and after 30 min at -20"C the tube was centrifuged (15 000 rpm, 5 min, 4 C) and the supernatant collected, concentrated by evaporation i n vacuo and dissolved i n 20 ul h^O. A) 5 pi of sample was mixed with non-radioactive u r a c i l , deoxyuridine and dUMP (20 nmol of each) and applied to a sheet of PEI-cellulose and developed with H^O. Distribution of radioactivity was compared to markers as described i n Materials and Methods. B) 5 yl of sample (prepared as in A) was applied to a sheet of DC cellulose and developed with isobutyric acid, NH.OH, H,0 (66:1:33, by v o l . ) and analysed as i n A.
ty from [ HlrllMP-labeled calf thymus RNA (prepared by E.coli RNA polymerase) or from uracil-containing nucleosides or mononucleotides (data not shown). Furthermore, release of H-uracil was inhibited by added uracil ( f i g . 4 ) , but not by deoxyuridine, uridine, dUMP, thymine, thymidine, dTMP, cytosine, deoxycytosine and araC which were a l l present at 5 mM concentrations.
Conditions and requirements for uracil-DNA glycosylase
Monovalent salt up to 60 mM stimulated the a c t i v i t y of uracil-DNA glycosylase 3-5 f o l d , with nearly identical results being found with NaCl, KC1 and NH-C1. Higher concentrations were inhibitory. A 20% stimulation was observed by about 1 mM MgCK, but the enzyme retained more than 90% of maximal act i v i t y in the presence of 5 mM EDTA; thus the enzyme apparently does not require divalent cations. Other divalent cations inhibited the enzyme a c t i v i t y . The order of inhibition was HgCl 2 »ZnCl 2 >Ni(N0 3 ) 2 S CoCl 2 >CuS0 4 >CdCl 2 >MnCl 2 > CaCl 2 >MgCl 2 . For graphical c l a r i t y , the results concerning CoCK, MnCl 2 and CaCl 2 are not presented in figure 2 .
N-ethylmaleimide (1 or 5 mM) had no effect on the enzyme a c t i v i t y . However, p-hydroxymercuribenzoate (0.5 -2.5 mM) inhibited uracil-DNA glycosylase by 90-95%. A pH of 7.5 was optimal; there was, however, no distinct pH optimum and 80% of f u l l activity was seen at pH 6.5 and 8.5 (Tris-HCl buffer).
Molecular weight of uracii-DNA glycosylase
The molecular weight of the native enzyme was determined by sedimentation in a glycerol gradient with cytochrome C (13 370), phospholipase C from B.cereus (23 000) and E.coli pol I (109 000) as internal size markers ( f i g . 3A) . The results from three separate experiments gave identical results, suggesting a native molecular weight of 17 000 -18 000. When the enzyme was sedimented in a 5-20% sucrose gradient in the presence of 200 mM NaCl, 20 mM TrisHCl pH 7.5 and 0.2 mM mercaptoethanol, the apparent molecular weight was also around 18 000. Also here uracil-DNA glycosylase sedimented has a symmetrical peak between the internal markers phospholipase C and cytochrome C (data not shown). However, g e l f i l t r a t i o n on Sephadex G-75 superfine gave a much higher molecular weight of about 50 000. Identical results were seen in the presence of 500 mM NaCl ( f i g . 3B) and 100 mM NaCl (data not shown).
Substrate u t i l i z a t i o n and inhibition by DNA
The rate of uracil release was about 3-fold higher from single stranded dUMP-containing DNA than from the corresponding double-stranded substrate. The Km for uracil-DNA glycosylase was about 0.7 yM (with respect to uracil) with double stranded [ H]dUMP-DNA as substrate, as determined by double reciprocal plots (18) . Double-stranded calf thymus DNA was a weak inhibitor (50% inhibition at 0.7 mg/ml) whereas heat-denatured DNA strongly inhibited u r a c i l -DNA glycosylase (50% inhibition at 0.05 mg/ml). The enzyme clearly preferred dUMP located internally in the chain, because the rate of release of uracil from DNA containing dUMP at the 3'-OH end was less than 5% of that of the cont r o l , which was standard substrate ( f i g . 4). In an effort to define more precisely some of the features required of a substrate for this enzyme, mixed deoxy-ribo-polymers containing [ H]dUMP were prepared as described above. The rate of release of H-uracil decreased progressively as one, two or three ribonucleotides substituted for the corresponding deoxyribonucleotide. Thus, when the nucleic acid contained rCMP, rGMP and rAMP in addition to [ HjdUMP, the release of uracil was less than 3» of that of the control, but s t i l l detectable ( f i g . 4). The l a t t e r polymer contained almost 50' J of the C 3 H]dUMP at the 3'-0H end, but mixing experiment (equal amounts of standard substrate plus substrate with [ HldUMP at the 3'-0H end, or standard substrate plus the polymer with three ribonucleotides) showed that dUMP at the 3'-OH end of DNA did not significantly i n h i b i t release of uracil from dUMP located internally in the 
DISCUSSION
Uracil-DNA glycosylase appears to be present in most, i f not a l l , p r o l i f erating cells (5) . In eukaryotic c e l l s , i t is present in nuclei, cytoplasma and mitochondria (10). I t is not known whether these a c t i v i t i e s represent d i f f erent species of the enzyme. However, human lymphocytes contain two chromatographically separable uracil-DNA glycosylase a c t i v i t i e s , one of which increases about 10-fold after treatment of the cells with phytohemagglutinin (20) .
The data in the present paper, as well as in two other recent papers (8, 21) , demonstrate that the eukaryotic enzymes have many properties in common with their prokaryotic counterparts; they are relatively small enzymes, are i n h ibited by u r a c i l , have no requirement for divalent cations and are not i n h i b ited by N-ethyl maleimide, but are inhibited by p-hydroxymercuribenzoate (6). However, the eukaryotic enzymes appear to have a Km around 1 yM, which is at least two orders of magnitude higher than that of the corresponding prokaryotic enzymes (5,7).
Reports on the apparent molecular weight of the native enzyme from mammalian systems have given different values of about 28 000 (8,21), 40-42 000 (20) and 50-55 000 (2). The results with enzymes from human tissues and cells also vary. The discrepancy between our sedimentation and gelfiltration results (18 000 and 52 000, respectively) suggests that the enzyme is probably not a simple spherical molecule. Surprisingly, the calf thymus enzyme was not inhibited by uracil, but instead was highly sensitive to relatively low concentrations (50 pM) of dTMP, thymine and thymidine (21) . In our studies we found that among the naturally occuring, mononucleotides, nucleosides and bases, only uracil was inhibitory to uracil-DNA glycosylase. Furthermore, among seven uracil analogs tested only 5-aza-uracil and 6-aminouracil inhibited the enzyme to the same extent as did uracil. Caradonna and Cheng (8) tested 13 uracil analogs (including two that we have also tested); non of these analogs inhibited the enzyme. These workers did not, however, test 5-azauracil and 6-aminouracil. It was reported that E.coli uracil-DNA glycosylase released 5-fluorouracil slowly from deoxyribonucleic acid, a finding compatible with our observation that 5-fiuorouracil is a weak inhibitor of uracil-DNA glycosylase (22) . If one assumes that inhibition by free base is an indication of which modified bases in DNA the uracil-DNA glycosylase would be able to recognize, the studies with uracil analogs suggest that the enzyme is very selective. Non of the tested analogs having modifications at positions 1-4 in the pyrimidine ring are inhibitory, but some changes at positions 5 or 6 are not discriminated against.
Our studies with various ribonucleotide-containing polymers indicate that deoxynucleotide residues near the dUMP residue are important for enzyme binding and/or recognition of dUMP as a substrate. An increasing inability to excise U correlated well with the number of rNMPs replacing the corresponding dNMPs. We also found that dUMP at the 3'-OH end of DNA is a poor substrate. Since single stranded chains are better substrates than double stranded ones, the complementary chain not containing dUMP is not necessary for binding or excision of U; in fact, excision of U from single strand is about 3-times faster than from double strands. Furthermore, uracil is released as fast, if not faster, from a poly(dU) • poly(rA) duplex than from a poly(dU) • poly(dA) duplex, indicating that ribose in the complementary chain does not disturb the enzyme (H. Krokan, unpublished). The exact mechanism by which uracil-DNA glycosylase recognizes a substrate might be elucidated by studying the interaction between a homogenous enzyme and a set of DNAs with known sequences containing a dUMP residue internally.
